IL-10 deficiency augments acute lung but not liver injury in hemorrhagic shock.
暂无分享,去创建一个
[1] Y. Vodovotz,et al. The Role of Fracture-Associated Soft Tissue Injury in the Induction of Systemic Inflammation and Remote Organ Dysfunction After Bilateral Femur Fracture , 2008, Journal of orthopaedic trauma.
[2] Y. Vodovotz,et al. PATTERNS OF CYTOKINE RELEASE AND EVOLUTION OF REMOTE ORGAN DYSFUNCTION AFTER BILATERAL FEMUR FRACTURE , 2008, Shock.
[3] E. Mazzon,et al. Absence of endogenous interleukin-10 enhanced organ dysfunction and mortality associated to zymosan-induced multiple organ dysfunction syndrome. , 2008, Cytokine.
[4] I. Chaudry,et al. KERATINOCYTE-DERIVED CHEMOKINE PLAYS A CRITICAL ROLE IN THE INDUCTION OF SYSTEMIC INFLAMMATION AND TISSUE DAMAGE AFTER TRAUMA-HEMORRHAGE , 2007, Shock.
[5] I. Chaudry,et al. Monocyte chemoattractant protein-1 influences trauma-hemorrhage-induced distal organ damage via regulation of keratinocyte-derived chemokine production. , 2007, American journal of physiology. Regulatory, integrative and comparative physiology.
[6] D. Herndon,et al. CYTOKINE EXPRESSION PROFILE OVER TIME IN SEVERELY BURNED PEDIATRIC PATIENTS , 2006, Shock.
[7] Timothy R Billiar,et al. Systemic inflammation and remote organ damage following bilateral femur fracture requires Toll-like receptor 4. , 2006, American journal of physiology. Regulatory, integrative and comparative physiology.
[8] C. Hauser. PRECLINICAL MODELS OF TRAUMATIC, HEMORRHAGIC SHOCK , 2005, Shock.
[9] I. Chaudry,et al. Role of IL-10 in regulating proinflammatory cytokine release by Kupffer cells following trauma-hemorrhage. , 2004, American journal of physiology. Gastrointestinal and liver physiology.
[10] L. Moldawer,et al. ROLE OF ENDOGENOUS INTERLEUKIN‐10 IN LOCAL AND DISTANT ORGAN INJURY AFTER VISCERAL ISCHEMIA‐REPERFUSION , 2003, Shock.
[11] K. Asadullah,et al. Interleukin-10 Therapy—Review of a New Approach , 2003, Pharmacological Reviews.
[12] J. Takala,et al. Increased Hepatosplanchnic Inflammation Precedes the Development of Organ Dysfunction After Elective High-Risk Surgery , 2002, Shock.
[13] I. Chaudry,et al. Resistance of macrophages to the suppressive effect of interleukin-10 following thermal injury. , 2001, American journal of physiology. Cell physiology.
[14] P. Giannoudis,et al. Immediate IL-10 expression following major orthopaedic trauma: relationship to anti-inflammatory response and subsequent development of sepsis , 2000, Intensive Care Medicine.
[15] J. Kirkpatrick,et al. The effects of interleukin-10 in hemorrhagic shock. , 2000, The Journal of surgical research.
[16] T. van der Poll,et al. Interleukin 10 inhibits the release of CC chemokines during human endotoxemia. , 2000, The Journal of infectious diseases.
[17] J. Lederer,et al. Protective effects of early interleukin 10 antagonism on injury-induced immune dysfunction. , 1999, Archives of surgery.
[18] H. Moriwaki,et al. Interleukin-10 inhibits hepatic injury and tumor necrosis factor-alpha and interferon-gamma mRNA expression induced by staphylococcal enterotoxin B or lipopolysaccharide in galactosamine-sensitized mice. , 1999, Journal of hepatology.
[19] K. Hanaoka,et al. Effects of sevoflurane and isoflurane anesthesia on arterial ketone body ratio and liver function , 1999, Acta anaesthesiologica Scandinavica.
[20] M. Perretti,et al. Role of resident peritoneal macrophages and mast cells in chemokine production and neutrophil migration in acute inflammation: evidence for an inhibitory loop involving endogenous IL-10. , 1999, Journal of immunology.
[21] J. Cone,et al. Interleukin-10 reduces morbidity and mortality in murine multiple organ dysfunction syndrome (MODS) , 1998 .
[22] Domschke,et al. IL‐4, IL‐10 and IL‐13 down‐regulate monocyte‐chemoattracting protein‐1 (MCP‐1) production in activated intestinal epithelial cells , 1998, Clinical and experimental immunology.
[23] T. Hartung,et al. Interleukin-10 counterregulates proinflammatory cytokine-induced inhibition of neutrophil apoptosis during severe sepsis. , 1997, Blood.
[24] U. Steckholzer,et al. Relationship of interleukin-10 plasma levels to severity of injury and clinical outcome in injured patients. , 1997, The Journal of trauma.
[25] J. Reynolds,et al. Interleukin-10. A role in the development of postoperative immunosuppression. , 1997 .
[26] K. Matsushima,et al. T helper 2 cytokines differently regulate monocyte chemoattractant protein-1 production by human peripheral blood monocytes and alveolar macrophages. , 1996, Journal of immunology.
[27] A. Morelli,et al. Interleukin 10 reduces lethality and hepatic injury induced by lipopolysaccharide in galactosamine-sensitized mice. , 1996, Gastroenterology.
[28] M. Burdick,et al. The Association between Mortality Rates and Decreased Concentrations of Interleukin-10 and Interleukin-1 Receptor Antagonist in the Lung Fluids of Patients with the Adult Respiratory Distress Syndrome , 1996, Annals of Internal Medicine.
[29] J. Dipiro,et al. Interleukin-10 is associated with the development of sepsis in trauma patients. , 1996, The Journal of trauma.
[30] L. Moldawer,et al. Human tumor necrosis factor receptor (p55) and interleukin 10 gene transfer in the mouse reduces mortality to lethal endotoxemia and also attenuates local inflammatory responses , 1995, The Journal of experimental medicine.
[31] B. Dewald,et al. Interleukin‐10 differentially regulates cytokine inhibitor and chemokine release from blood mononuclear cells and fibroblasts , 1995, European journal of immunology.
[32] R. Winchurch,et al. Effect of anesthesia and surgery on plasma cytokine levels. , 1993, Journal of critical care.
[33] M. Howard,et al. Interleukin 10 protects mice from lethal endotoxemia , 1993, The Journal of experimental medicine.
[34] T. Mosmann,et al. IL-10 inhibits cytokine production by activated macrophages. , 1991, Journal of immunology.
[35] J. Siegel,et al. Neutrophil oxidative burst activation and the pattern of respiratory physiologic abnormalities in the fulminant post-traumatic adult respiratory distress syndrome. , 1991, Circulatory shock.